Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2021 10:21 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HBC

James Berger, Chief Commercial Officer in Hofseth BioCare ASA, has today 01.10.2021 purchased 30,000 shares through his wholly-owned company Nevera AG, at an average price of NOK 6,65 per share. ...
September 22, 2021 02:15 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC ONBOARDS EX-NOVARTIS AND EX-PFIZER SENIOR REGULATORY AFFAIRS PROFESSIONAL, DR ZUBAIR HUSSAIN

HBC is delighted to announce the appointment of Dr Zubair Hussain as Senior Regulatory Consultant from September 2021. Dr Hussain has over 25 years’ experience in Regulatory Affairs and has held...
September 17, 2021 02:02 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC HIRES EX DKSH SENIOR EXECUTIVE DR TANJA SCHAFFER, TO HEAD UP ITS GLOBAL INGREDIENTS BUSINESS AND AS CEO OF HBC SWITZERLAND GMBH

HBC is delighted to announce the hiring of Dr Tanja Schaffer as Executive Vice President for HBC’s Global Ingredients division and as CEO of HBC's new Swiss subsidiary HBC Switzerland GmbH. The...
August 30, 2021 07:21 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

Roger Hofseth has today, 30 August 2021, bought 50,000 shares at an average price of NOK 7.2867 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the transaction, Mr....
August 27, 2021 02:10 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: SECOND QUARTER 2021 FINANCIAL REPORT

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Hofseth BioCare ASA (“HBC”) had net sales revenues of NOK 31.0m (19.9m) in...
May 25, 2021 04:22 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA («HBC») has today purchased 50,000 shares in HBC at an average price of NOK 7.7295 per share. As a...
May 21, 2021 02:44 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: FIRST QUARTER 2021 FINANCIAL REPORT

HBC had net sales revenues of NOK 16.8m (10.4m) in the first quarter and gross operating revenues of NOK 16.8m (18.5m). Gross revenues in first quarter 2020 included NOK 8.2m in insurance claim...
May 12, 2021 02:45 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: GLOBAL INNOVATION PARTNERSHIP WITH CATALENT TO DEVELOP DELAYED-RELEASE FORMULATION OF OMEGO FISH OIL

ÅLESUND, NORWAY – May 12, 2021 — Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, today announced that it has begun a global...
April 23, 2021 08:03 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING

The AGM in Hofseth BioCare ASA was held in Havnegata 11, Ålesund today on Friday 23 April 2021. All the matters were decided according to the proposals in the notice. Please find the minutes from the...
April 15, 2021 02:00 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: IMCD AND HBC EXTEND INTERNATIONAL AGREEMENT TO INCLUDE EUROPE

European Biotech and consumer health company HBC has confirmed plans to extend an exclusive distribution agreement for its marine branded products with leading speciality chemicals and ingredients...